|
|
||||||||
E (CD103)-Deficient Mice1



*
Division of Rheumatology, Immunology, and Allergy, and
Division of Genetics, Brigham and Womens Hospital and Harvard Medical School, Boston, MA 02115;
Department of Immunology and Infectious Disease, Harvard School of Public Health, Boston, MA 02115; and
§
Department of Medicine, University of Connecticut Health Center, Farmington, CT 06030
| Abstract |
|---|
|
|
|---|
E(CD103)ß7 is thought to be important for
intraepithelial lymphocyte (IEL) localization or function. We cloned
the murine integrin gene encoding
E, localized it to
chromosome 11, and generated integrin
E-deficient mice.
In
E-/- mice, intestinal and vaginal IEL
numbers were reduced, consistent with the known binding of
Eß7 to E-cadherin expressed on epithelial
cells. However, it was surprising that lamina propria T lymphocyte
numbers were diminished, as E-cadherin is not expressed in the lamina
propria. In contrast, peribronchial, intrapulmonary, Peyers patch,
and splenic T lymphocyte numbers were not reduced in
E-deficient mice. Thus,
Eß7
was important for generating or maintaining the gut and vaginal T
lymphocytes located diffusely within the epithelium or lamina propria
but not for generating the gut-associated organized lymphoid tissues.
Finally, the impact of
E deficiency upon intestinal IEL
numbers was greater at 34 wk of life than in younger animals, and
affected the TCR
ß+ CD8+ T cells more than
the 
T cells or the TCR
ß+
CD4+CD8- population. These findings suggest
that
Eß7 is involved in the
expansion/recruitment of TCR
ß+ CD8+ IEL
following microbial colonization. Integrin
E-deficient
mice will provide an important tool for studying the role of
Eß7 and of
Eß7-expressing mucosal T lymphocytes in
vivo. | Introduction |
|---|
|
|
|---|
ß and 
type, and
thymus-dependent vs -independent T cell development (reviewed in 5). There are estimated to be as many T lymphocytes in the intestinal
immune system as in the spleen (6). Furthermore, many infectious agents
invade via mucosal epithelia, emphasizing the importance of mucosal T
lymphocytes for immune surveillance and immune responses to mucosal
pathogens under normal conditions. In addition, intestinal T
lymphocytes have been implicated in the pathogenesis of inflammatory
bowel diseases, based upon the development of intestinal inflammation
in animals with defects in T lymphocyte regulation (7). Thus, it will
be important to understand the mechanisms whereby mucosal lymphocytes
selectively localize and function. Following primary stimulation in organized lymphoid tissues, such as mesenteric lymph nodes and Peyers patches, some activated intestine-derived lymphocytes recirculate and then preferentially return to the intestinal tract. The selective expression of chemokine receptors and adhesion molecules are thought to contribute to T cell homing (8). Once in the intestine, lymphocyte subpopulations localize to particular microenvironments. For example, the CD8+ T cells are found preferentially within the epithelium, where they comprise 90% of the resident population, whereas CD4+ T cells predominate in the lamina propria, where they constitute more than half of the T lymphocytes (9). Targeted migration along chemokine gradients and selective adhesion to extracellular matrix or to cellular counterreceptors may account for the localization and retention of T cell subsets within mucosal microenvironments.
One candidate to mediate the selective localization or retention of
intraepithelial T lymphocytes is the integrin
E(CD103)ß7. This integrin is expressed
selectively on >90% of intestinal IEL and on 4550% of lamina
propria T lymphocytes (9, 10, 11) in both mice and humans. It is also found
on T lymphocytes in some other mucosal epithelia, such as the
genitourinary epithelium (12), on
40% of bronchioalveolar lavage T
cells obtained from normal humans (13) and on some cells of dendritic
morphology in rats (14). Furthermore,
Eß7
expression can be induced on T lymphocytes and murine mast cells by
culture in the presence of TGF-ß1 (15), a cytokine produced by
intestinal epithelial cells (16) as well as other cell types. In
contrast,
Eß7 is expressed on <5% of PBL
in humans (10), on only 15% of splenic T lymphocytes in mice (17), and
has not been found on B lymphocytes, underscoring its selective
expression on mucosal T cells.
The
Eß7 integrin mediates T cell adhesion
to epithelial cells (18) through its binding to E-cadherin (19, 20, 21), a
member of the cadherin family of adhesion molecules that is expressed
selectively on epithelial cells. Cadherins are characterized by their
tissue-specific distribution and are known to mediate homophilic
adhesion of cells within tissues (22). In addition, evidence has
suggested that
Eß7-dependent adhesion is
regulated by inside-out signals, based upon the observation that
Eß7 function is enhanced following
stimulation through the TCR (21). Integrin
Eß7 also appears to transmit an
intracellular signal, as anti-human
E mAbs enhance T
cell proliferation in response to suboptimal anti-CD3 stimulation
(9, 23), and as an anti-murine
E mAb induces T
cell-mediated lysis of FcR-bearing target cells in the absence of a
signal from the TCR (17). Thus, the
Eß7
integrin may be important in the localization or function of T cells,
dendritic cells, and/or mast cells.
To determine the role of
Eß7 in in vivo
immune responses, the murine integrin
E-encoding gene
(Itgae) was cloned and localized to chromosome 11. Then,
integrin
E-deficient mice were generated. Study of these
animals revealed an altered distribution of T lymphocytes within
epithelia and in the intestinal lamina propria, in the absence of
experimentally induced infection or inflammation. Thus, these studies
demonstrate an important role for
Eß7 in
modulating the homeostasis of T lymphocyte numbers in selected tissue
sites.
| Materials and Methods |
|---|
|
|
|---|
E-encoding gene (Itgae)
cloning
A murine 129/Sv-derived
-Fix II library (Stratagene, La
Jolla, CA) was screened by hybridization with an
E cDNA
probe incorporating nucleotides 10881253 of the murine
E cDNA sequence (15). Inserts were subcloned and partial
sequence determined by deletion cloning, followed by dideoxy chain
termination analysis. The nucleotide sequence within identified exons
was identical to nucleotides 142771 of the murine
E
cDNA reported previously with the exception of only 4/2757 bases
(nucleotide changes t411c, g668a, c1057g, and g1058c; amino acid
changes I207E and R337A).
Localization of the Itgae gene
Primers were designed to amplify a region corresponding to intronic sequence of Itgae to test for single-strand conformation polymorphisms (SSCPs) between mouse strains. These were analyzed as previously described (24). Briefly, oligonucleotides were radiolabeled with [32P]ATP using polynucleotide kinase, and genomic DNAs from a series of mouse strains were amplified using standard protocols (anneal at 55°C for 1 min, extend at 72°C for 2 min, and denature at 94°C for 1 min for 40 cycles, with a final extension at 72°C). A total of 2 µl of the amplified reaction was added to 8.5 ml USB (United States Biochemical) stop solution, denatured at 94°C for 5 min, and immediately placed onto ice. A total of 2 µl of each reaction is loaded on a 6% nondenaturing acrylamide sequencing gel and electrophoresed in 0.5x TBE buffer for 23 h at 40 W in a 4°-cold room. A primer pair based upon sequence in the intron between exons 2 and 3 (5-AAGGTCAGATGAGCAATATGT-3' (forward) and 5'-GCCAGCAGACTCAGCATTACT-3' (reverse)) identified a polymorphism between C57BL/6J and Mus spretus. This primer pair was used to analyze DNA prepared from the BSS ((C57BL/6JEi x SPRET/Ei)F1 x SPRET/Ei) backcross (25). The strain distribution pattern was analyzed using the Map Manager Program (26).
Construction of the
E targeting vector and
generation of
E-/- mice
A targeting construct was generated (Fig. 1
a) and transfected by
electroporation into the 129/Sv-derived embryonic stem cell line ES-D3.
Transfected cells were selected for G418 and gancyclovir resistance, as
reported previously (27), and cloned. Clones that incorporated a single
copy of the construct into the genome by homologous recombination were
identified by Southern blot analysis of genomic DNA using a 5' probe
(Fig. 1
a), a 3' probe, and the neomycin resistance gene.
Such clones were injected into BALB/c blastocysts to generate chimeric
animals. The
E+/- progeny of matings
between chimeric animals and BALB/c mice were intercrossed to generate
F2 (129/Sv x BALB/cJ) offspring, which were utilized
in these experiments except where otherwise indicated. Two independent
clones were used to generate chimeric animals that expressed similar
phenotypes. All animals were housed under specific pathogen-free (SPF)
conditions.
|
Genomic DNA was isolated from tail biopsies by proteinase K digestion, followed by phenol extraction. Southern blot analysis was performed using 10 µg genomic DNA, Hybond-N (Amersham, Arlington Heights, IL) filters and digoxigenin-labeled probes (Nonradioactive DNA labeling and detection kit; Boehringer Mannheim, Indianapolis, IN) according to standard procedures.
PCR was performed on genomic DNA using primer sequences flanking the inserted neomycin resistance gene to yield products of 1100 bp from disrupted and 900 bp from wild-type alleles (primers used: 5'-GCA ACA ACG CAT CGT TCA TAT GGA-3' and 5'-GTG CTC TGT CTA TTG TTC CCC TCC TT-3'; conditions: anneal at 62°C for 1 min, extend at 72°C for 2 min, and denature at 94°C for 1 min for 40 cycles, with a final extension at 72°C).
Cells and culture conditions
A single cell suspension of splenic leukocytes was stimulated
with 5 µg/ml Con A (Sigma, St. Louis, MO) and cultured for 5 days. A
total of 5 ng/ml human recombinant TGF-ß1 was added to the medium,
and the cells were grown for an additional 5 days to induce
E expression.
Purification of intestinal IEL, flow cytometry, and estimation of Peyers patch size
Intestinal IEL were isolated as described (28) with minor modifications. Briefly, small intestines were flushed with HBSS, trimmed to remove Peyers patches, opened longitudinally, and cut into 3- to 5-mm fragments. The fragments were incubated in a shaking water bath at a rate of 120 shakes per minute in medium (RPMI 1640 containing 104 U/ml penicillin/streptomycin, 20 µg/ml gentamicin, 2% bovine calf serum, and 20 mM HEPES buffer) at 37°C for 2030 min. The intestinal pieces were shaken manually for three cycles of 15 s each to release intestinal IEL. The resulting cell suspensions were collected, pooled, passed through a glass wool column, and the IEL separated from epithelial cells using 44/66% Percoll density gradient centrifugation. To estimate the size of Peyers patches, their length and width were multiplied to estimate their relative cross-sectional area in mm2. To isolate Peyers patch lymphocytes, the Peyers patches were mechanically disrupted by rubbing the patches between two frosted glass slides.
For FACS analysis, 105 cells were stained with saturating concentrations of mAb (buffer: 2% BSA, 0.05% NaN3 in PBS; blocking reagents: 10% mouse serum (for rat Abs) or 10% goat serum and 20 µg/ml mAb 2.4G2 (for hamster Abs)). In some experiments, dead cells were excluded by propidium iodide staining. Samples were analyzed using a FACScan and FACScalibur for four-color analysis and a FACSort and the Cell Quest software (Becton Dickinson, San Jose, CA) for one color analysis.
Cell surface iodination with 125I and immunoprecipitation
A total of 4 x 107 TGF-ß1-stimulated splenocytes was surface iodinated and then solubilized in TBS/0.5% Triton X-100 (Sigma). Then, 1 x 107 cell equivalents were precleared with protein G-Sepharose resin (Pharmacia, Piscataway, NJ), immunoprecipitated with 5 µg of purified mAb followed by protein G-Sepharose, washed, and the immunoprecipitated proteins were analyzed by SDS-PAGE using 7% gels under reducing conditions (29).
Abs
The following mAbs were used as controls: rat IgG1 (R59-40;
PharMingen, San Diego, CA), rat IgG2A (R35-95; PharMingen), rat IgG2B
(SFR3-DR5; American Type Culture Collection (ATCC), Manassas, VA), and
hamster IgG (UC8-4B3; PharMingen). The following Ags were detected by
mAbs: CD3
(500A2; PharMingen, and 145-2C11; ATCC), CD4 (RM4-5;
PharMingen), CD8
(53-6.72; ATCC), CD8ß (53-5.8; ATCC), CD11b
(
M integrin, Mac-1, M1/70; ATCC), CD18 (ß2
integrin, 2E6; ATCC), CD25 (IL-2R
-chain, 3C7; PharMingen), CD29
(ß1 integrin, Ha2/5; PharMingen), CD45R/B220 (RA3-6B2;
PharMingen), CD45RB (MB23G2; ATCC, and 16A; PharMingen), CD49a
(
1 integrin, Ha31/8; PharMingen), CD49b
(
2 integrin, HM
2; PharMingen), CD49d
(
4 integrin, P/S2, or R1-2; ATCC), CD49e
(
5 integrin, HM
5; PharMingen), CD49f
(
6 integrin, GoH3; Dianova, Hamburg, Germany),
CD49d/ß7 (
4ß7, DATK32 (30);
LeukoSite, Cambridge, MA), CD51 (
v integrin, H9.2B8;
PharMingen), CD54 (ICAM-1, YN1/1.7.4; ATCC), CD62L (L selectin, MEL-14;
ATCC), CD90 (Thy-1, AT15.E; R. MacDonald Ludwig Institute for Cancer
Research, Epalinges, Switzerland), CD103 (
E integrin,
M290 (11); P. Kilshaw, Department of Immunology, AFRC Babraham
Institute, Cambridge, U.K. or 2E7 (17); L. Lefrancois, Department of
Medicine, University of Connecticut Health Center, Farmington, CT),
ß7 (M293; P. Kilshaw), CD106 (VCAM-1, M/K-2.7; ATCC),
CD32/CD16 (Fc-
II/IIIR, 2.4G2; ATCC), MHC class I (M1/42.3, rat
IgG2A; ATCC), anti-TCR
ß (H57-597; PharMingen), and
anti-TCR 
(GL3; PharMingen). FITC-conjugated goat
anti-hamster and mouse anti-rat secondary Abs used in FACS or
direct immunofluorescent staining of intestinal sections were purchased
from Jackson ImmunoResearch (West Grove, PA), and biotinylated
goat-anti-hamster and mouse adsorbed rabbit-anti-rat serum were
obtained from Vector Laboratories (Burlingame, CA).
Histochemistry
For histochemistry, tissue samples were embedded in JB-4 plastic resin (Polysciences, Warrington, PA) and 3-µm sections stained with hematoxylin-eosin. For immunohistochemistry, tissue samples were frozen in OCT and 5- to 10-µm cryostat-cut sections stained using the ABC (avidin/biotin complex)-immunoperoxidase kit according to the manufacturers instructions (Vector Laboratories). For analysis of lamina propria T cell numbers, a cell was counted as a lamina propria lymphocyte if it did not overlap the basement membrane and was contained within villi rather than crypts. This criteria may account for the unusually high ratio of CD4+/CD8+ T cells observed within the lamina propria in these studies, as some cells were counted as IEL that were largely within the lamina propria. For analysis of T cell numbers within vaginal tissue sections, the number of intraepithelial T lymphocytes within an entire tissue section derived from the middle third of the vagina was determined and expressed per mm basement membrane. For evaluation of T lymphocyte numbers within lung tissue, the left lung was frozen in OCT, the average number of anti-CD3 mAb stained cells in at least seven randomly selected high power (40x) fields was determined and used to calculate the number of T lymphocytes/mm2. In addition, the average number of CD3+ cells per bronchus was determined evaluating all of the bronchi within these randomly located tissue sections.
Statistical analysis
Statistical analysis was performed using an unpaired, two-tailed Students t test when n = 3 and the Mann-Whitney nonparametric U test when n > 3, unless otherwise indicated. Analysis was performed using the Instat software (GraphPad Software, San Diego, CA).
| Results |
|---|
|
|
|---|
Genomic clones encoding murine
E were identified by
hybridization with PCR products encoding fragments of the murine
E cDNA (GenBank accession nos. AF133070-AF133085). Based
upon comparison with the murine
E cDNA sequence (15) and
identification of the conserved consensus splice sites (Ref. 31, and
data not shown), a partial map of the murine
E
intron/exon structure was generated (Fig. 1
a). To determine
the chromosomal location of Itgae, SSCP analysis was used as
previously described (24). Primers corresponding to intronic sequence
between exons 2 and 3 of Itgae were analyzed and found to
identify an SSCP between inbred mouse strains (see Materials and
Methods). The BSS-interspecific backcross was genotyped and the
allele distribution pattern analyzed using the Map Manager program.
Itgae was found to map to chromosome 11 with a logarithm of
odds likelihood score of 27.4. No recombinants were found in 91 progeny
between Itgae and the marker D11Abb1. The
position of Itgae with respect to flanking microsatellite
markers was: D11 Mit4 - 5.5 ± 2.4 cm -
Itgae, D11Abb1 - 1.1 ± 1.1 cM - D11
Mit7, D11 Mit32, D11 Mit34 (mapping data submitted to
the Mouse Genome Database).
Integrin
E-deficient mice were generated
To generate integrin
E-deficient mice, exon 10
within the integrin
E-encoding gene was replaced with a
neomycin resistance gene by homologous recombination (Fig. 1
, ac). FACS analysis confirmed that intestinal IEL isolated
from
E-/- mice lacked
E
expression (Fig. 1
d). In addition, splenocytes from
E-/- mice were cultured in the presence of
TGF-ß1, a cytokine that up-regulates
E expression on
wild-type T cells. Integrin
E was not detected on the
surface of TGF-ß1-treated splenocytes derived from
E-/- mice by immunoprecipitation or FACS
analysis. In contrast, it was readily detected on the surface of cells
derived from
E+/+ animals, and was detected
at reduced levels on cells from
E+/-
animals (Fig. 1
e, and data not shown). Thus,
E-/- mice lacked expression of the
E polypeptide, while heterozygous animals expressed
intermediate levels of
Eß7 both in
immunoprecipitation (Fig. 1
e) and in FACS analysis (data not
shown). Integrin
E deficiency did not alter fecundity,
morphogenesis, or overall weight gain, and most animals survived for
>18 mo in a SPF facility (data not shown).
Integrin
E-deficient mice had normal or increased
numbers of splenic T lymphocytes
Because
E is selectively expressed on leukocytes,
studies were performed to determine the impact of
E
deficiency upon the histologic appearance of organized lymphoid
tissues. In this initial evaluation,
E deficiency had no
apparent effect on the size of the thymus or on the immunohistologic
appearance of the thymus, peripheral lymph nodes, or spleen after
staining with anti-CD3, anti-CD4, and anti-CD8 mAbs. In
addition, there were no changes in the serum levels of IgM, IgG
isoforms, or IgA in
E-/- as compared with
E+/+ mice (data not shown).
To further evaluate the impact of
Eß7
expression upon the number and subset composition of splenic T
lymphocytes, additional studies were performed. First, the overall
number of leukocytes/spleen after RBC lysis was similar in
E-/- and
E+/+
mice three to four generations backcrossed toward the C57BL/6 strain
and then intercrossed (N34)
(
E-/- mice: 1.07 ± 0.15 x
108 cells/spleen;
E+/+ mice:
1.14 ± 0.16 x 108 cells/spleen;
n = 3; p = 0.55). In addition, flow
cytometry was used to determine the total number of splenocytes
expressing CD3, CD4, or CD8 using the formula: (the total number of
splenocytes) x (the proportion of the total splenocyte population that
expressed each marker). In this analysis, the number of
CD3+, CD4+, and CD8+ splenocytes
was not altered significantly by
E deficiency. In
contrast, when mice N10 to the BALB/c strain were
evaluated, the total number of splenic leukocytes was increased by 24%
in
E-deficient mice (
E-/-
mice: 1.07 x 108 ± 0.11 cells/spleen;
E+/+ mice: 0.86 x 108 ±
0.04 cells/spleen; n = 3; p = 0.04). In
addition, the numbers of CD3+, CD4+, and
CD8+ splenocytes were increased by 14%, 28%, and 13%,
respectively in
E-/- mice (Fig. 2
), while
CD4+CD8+ double positive splenic T cells were
not detected in either
E+/+ or
E-/- mice (n = 1, pooling
cells isolated from three mice of each genotype, data not shown).
Overall, peripheral lymphocyte compartments appeared similar in
E-/- and
E+/+
mice, with a trend toward increased numbers of CD4+ and
CD8+ splenic T cell numbers in
E-/- animals on the BALB/c genetic
background.
|
E-deficient mice had fewer T cells
diffusely distributed within the intestinal and vaginal epithelia
The number of intestinal IEL in adult
E-/- and
E+/+
littermates also was compared by immunohistology, with the expectation
that intestinal IEL numbers would be reduced by
E
deficiency due to the loss of the
Eß7/E-cadherin-mediated adhesion. Indeed,
the number of jejunal IEL was reduced by 54% in the
E-/- progeny of F2
(BALB/c x 129/Sv) mice as compared with
E+/+ mice of similar genetic background
(p < 0.002, Mann-Whitney U test;
n = 5
E+/+ and 8
E-/- mice) (Figs. 3
and
4a). In these studies, it was
apparent that the number of intestinal IEL was influenced by genetic
background and/or environment, as there were more intestinal IEL in
E+/+ mice on the (129/Sv x BALB/c) or
the C57BL/c backgrounds than on the BALB/c background. However,
E-/- mice had reduced intestinal IEL
numbers in all genetic backgrounds examined, including groups of mice
housed in two independent animal facilities. Thus, reduced intestinal
IEL numbers represents a consistent feature of
E-deficient mice.
|
Eß7 is also expressed on
T cells in or adjacent to other mucosal epithelia, such as the lung and
genitourinary tract, the number of T lymphocytes in these other sites
was compared in
E-/- and
E+/+ mice. While vaginal IEL numbers were
reduced by 60% (p < 0.01; n =
3) (Fig. 4
E-/- mice of
mixed (129/Sv x BALB/c) genetic background, the number of T cells
within the lung parenchyma and adjacent to the bronchi was not affected
by
E deficiency (Fig. 4
E-/- mice had reduced
numbers of T cells within some epithelia, including the intestine and
vagina, but not in others, such as in the peribronchial regions in the
lung.
|
E-deficient mice have reduced numbers of
lamina propria T cells but not of Peyers patch T cells
It appeared that the number of lamina propria T lymphocytes was
reduced in immunohistochemical analysis of tissue sections from
(129/Sv x BALB/c) mice. This was not an expected finding because
E-cadherin, the known
Eß7 counterreceptor,
is not expressed in the lamina propria (32). To quantitate this
difference, the number of T lymphocytes within the villus lamina
propria that did not appear to be in contact with either the basement
membrane or epithelium was determined per 0.5-mm villus length. In this
analysis, the number of lamina propria lymphocytes was significantly
diminished by
E deficiency in animals of the
(129/Sv x BALB/c) background (CD3+ lamina propria
lymphocytes/0.5-mm villus length in
E+/+
mice: 76 ± 6 vs 39 ± 9 in
E-/-
mice; p < 0.01; n = 3). In a second
group of mice partially backcrossed toward the BALB/c strain, integrin
E deficiency had a similar impact upon lamina propria T
lymphocyte numbers (in
E+/+ mice, 70 ±
7 T cells/0.5-mm villus length vs 30 ± 6 in
E-/- mice; p = 0.002;
n = 3). Thus,
E-/- mice
had significantly fewer lamina propria T lymphocyte numbers than
E+/+ mice in these two groups. However, when
additional groups of mice were evaluated,
E deficiency
did not appear to have an impact upon lamina propria T lymphocyte
numbers (Fig. 5
a). In these
two additional groups, it was notable that the
E+/+ mice had fewer lamina propria T
lymphocytes than those in the groups initially studied (Fig. 5
a). This could be due to differences in genetic background,
as these later groups of mice were backcrossed toward either the
C57BL/6 or BALB/c strains. However, it seems more likely that
environmental factors may have had an effect. Of note with respect to
this possibility, the two more fully backcrossed groups of mice were
housed in an animal facility where the cages were changed twice/wk, and
the microisolator cages were vented with an air circulation system.
These animals had relatively few lamina propria T lymphocytes and
E deficiency had no effect on lamina propria T cell
numbers. In contrast, the other groups of mice were housed in a
facility where the cages were changed once/wk, and the microisolator
cages were not vented. In the setting of this less-stringent
environment, there were more lamina propria T lymphocytes in
E+/+ mice, and
E deficiency
had a significant impact upon lamina propria T lymphocyte numbers.
|
E-/- mice,
the size of Peyers patches was increased in the first cohort of mice
examined. However, Peyers patch size was not altered in three
additional groups of mice of different genetic backgrounds, and the
proportion of Peyers patch cells expressing CD3, CD4, or CD8 was not
altered (Fig. 5
E-/- as compared with
E+/+ mice, based upon immunohistochemistry
after staining with anti-CD3 mAbs. These findings demonstrate that
Peyers patch size and T lymphocyte composition are not, on average,
altered by
E deficiency. However, it is possible that
E deficiency results in enlarged Peyers patch size
when present in a given genetic background or under some environmental
conditions.
Integrin
E disruption has a preferential effect upon
ß T cell localization
The 
T cells populate the intestinal epithelium at an
earlier age than
ß T cells (33, 34) and the recruitment/expansion
of TCR
ß+ intestinal IEL depends upon microbial
colonization of the intestinal tract (33). Thus, studies were performed
to determine at what age reduced numbers of intestinal IEL were
detected in
E-deficient animals. In immunohistochemical
analyses, intestinal IEL were not observed until 5 days of age in
either
E+/+ or
E-/- mice. By 3 wk of age, the intestinal
IEL number increased to 4050 intestinal IEL/1000 epithelial cells in
E+/+ mice, with only a 20% reduced number
of intestinal IEL in
E-/- mice. Finally,
the intestinal IEL number reached a plateau in animals of both
genotypes at 45 wk of age. In mice older than 5 wk of age, the number
of proximal jejunal IEL in
E-/- mice was
only 46% of that seen in
E+/+ mice (Fig. 6
). Overall, this kinetic analysis
suggested that
E might be more important in the
localization of
ß than of 
T cells and that the impact of
E deficiency upon intestinal IEL numbers becomes
apparent at a time when TCR
ß cells are increasing in number,
presumably due to bacterial colonization.
|
E is more important in the localization of
TCR
ß than of 
T cells, then one would predict that adult
E-deficient mice would have an intestinal IEL TCR
repertoire skewed toward a lower proportion of TCR
ß+
cells. To test this possibility, the proportion of IEL expressing each
TCR was evaluated by flow cytometry in populations isolated from
E+/+,
E+/-, or
E-/- mice. Mice N34 to the
C57BL/6 strain were used for this study because
E
deficiency had a greater impact upon IEL number in the C57BL/6 than in
the BALB/c genetic background and because the (129/Sv x BALB/c)
mice were no longer available. In these studies, TCR gene segment usage
was similar in
E+/- and
E+/+ mice (data not shown), despite the
reduced levels of
E expressed on
E+/- T lymphocytes (Fig. 1
ß+ intestinal
IEL was 54% in
E+/- or
E+/+ mice, it was only 35% in
E-/- mice (p <
0.01; n = 4
E-/- and 6
E+/+ or
E+/-)
(Fig. 7
ß+ IEL
E-/- mice was accompanied by a
corresponding increase in the relative proportion of IEL that expressed
the 
TCR. Thus, in
E-/- mice, the
number of intestinal IEL that expressed the TCR-
ß was reduced more
than that of 
TCR-expressing cells.
|
E disruption reduced the numbers of
CD8+ TCR
ß+ IEL subsets but had a lesser
impact upon the number of CD4+ IEL
Within the intestinal epithelium,
Eß7
is expressed by >90% of the CD8+ T cells but by only half
of the CD4+ T cells (9, 11). Thus, it seemed likely that
Eß7 disruption might affect the number of
CD8+ IEL more than the number of CD4+ IEL.
Thus, three-color FACS analysis was performed to evaluate the subsets
of TCR
ß+ intestinal IEL in
E-/- as compared with
E+/- or
E+/+
mice backcrossed toward the C57BL/6 strain, in which the TCR 
/TCR
ß cell ratio was altered (Fig. 7
a). In this analysis,
the proportions of intestinal TCR
ß+ IEL that
expressed CD8
, CD8
ß, or both CD4 and CD8 were not
consistently altered in
E-/- as compared
with
E+/- or
E+/+ mice (Fig. 7
, b and
c). However, the proportion of TCR
ß+ IEL
that were CD4+CD8- was greater in
E-/- than in
E+/+ or
E+/-
mice (7.3 ± 0.9% of the IEL in
E+/+
or
E+/- mice vs 12.9 ± 1.0% of the
IEL in
E-/- mice; n = 4;
p = 0.028). As the total number of IEL was reduced to
50% of normal, an apparent doubling of the
CD4+CD8- subset suggests that
CD4+CD8- T cell numbers were not increased but
rather remained unchanged, while the other subsets were reduced in
number in
E-deficient mice. In contrast, in the BALB/c
strain, where
E deficiency had relatively little impact
upon IEL numbers (Fig. 4
a), the proportion of IEL that
expressed CD4 was not altered in
E-deficient mice (Fig. 8
). Finally, within the lamina propria of
mice backcrossed toward the C57BL/6 strain, the CD4+ and
CD8+ populations both were reduced in number with a
slightly greater impact upon the number of CD4+ cells (Fig. 5
a). Overall,
E deficiency resulted in
diminished numbers of CD8+ IEL but not of CD4+
IEL in backgrounds where
E deficiency had a dramatic
impact upon IEL numbers, but resulted in reduced numbers of both
CD4+ and CD8+ lamina propria subpopulations.
|
E deficiency, the expression of CD44 was
increased
Given the expression of
Eß7 on >80%
of intestinal IEL, it was surprising that the intestinal IEL numbers
were reduced by only 30% in mice partially backcrossed to the BALB/c
strain. Thus, additional FACS analyses were performed to determine
whether
E-/- IEL derived from mice
N34 to BALB/c express higher levels of an adhesion
molecule that might functionally compensate for
E
deficiency in IEL localization, and thus reduce the impact of
E deficiency on intestinal IEL number. Importantly, the
expression of
4ß7, the other
ß7 integrin, was not altered on intestinal IEL or
Peyers patch lymphocytes (Fig. 8
, and data not shown). While there
were some interindividual variations in cell surface expression of
other adhesion receptors, many adhesion molecules were expressed, on
average, at similar levels on intestinal IEL isolated from
E-/- or
E+/+
mice. These included CD18 (LFA-1 ß2-chain), CD54
(ICAM-1), CD62L (L-selectin), CD29 (ß1 integrin subunit),
CD49d (
4), and CD49a (
1 integrin subunit)
(Fig. 8
). Other adhesion molecules were not detected on intestinal IEL
isolated from either
E-/- or
E+/+ mice, including CD49b
(
2), CD49e (
5), CD49f (
6),
and CD51 (
V) (data not shown). Overall, these studies
emphasize the relatively limited expression of other adhesion
molecules, such as the ß1 integrins, on intestinal IEL.
On IEL derived from
E-/- mice, the only
consistent shift in adhesion molecule expression was increased
expression of CD44 (average mean fluorescence intensity (MFI) 118 on
cells derived from
E-/- mice vs 78 on
cells derived from
E+/+ mice;
n = 4; p < 0.03), a hyaluronate
receptor (35, 36). This molecule could participate in mucosal T cell
adhesion within the intestinal mucosa, as hyaluronate is expressed
within the lamina propria (37). In addition, CD45RB was expressed a
slightly higher levels on IEL derived from
E-/- than on IEL derived from
E+/+ mice (average MFI = 890 vs 780;
p = 0.0005; n = 3, not visible in the
profile due to the logarithmic scale). This finding, while highly
reproducible, was of unclear functional significance.
| Discussion |
|---|
|
|
|---|
E-encoding gene
was strikingly similar to that of other I-domain containing integrins,
M and
X (38, 39), with a high degree of
conservation in the intron/exon boundaries and exon spacing. In
addition, an exon was identified between exons 5 and 6 that was not
homologous to exons within other integrins, suggesting that it may have
resulted from a gene-insertion event. This exon encoded 44 amino acids,
corresponding to the X-(extra)-domain identified within the predicted
human
E (40) and murine
E subunits (15)
(Fig. 1
E was designated E (Fig. 1
In the
E -/- mice, there were reduced
numbers of intestinal IEL in three different genetic backgrounds,
evaluating mice housed in two different animal facilities. Thus,
reduced intestinal IEL numbers was a consistent feature of
E deficiency, although the magnitude of this effect
varied with genetic background and/or environment. IEL numbers were
also reduced in the vaginal epithelium, while the number of lymphocytes
in lung parenchyma or adjacent to the bronchiolar epithelium was
not affected. While lamina propria T lymphocyte numbers also were
diminished by
E deficiency in some strains and/or
environmental conditions, the number of T lymphocytes in Peyers
patches and spleen was not diminished by disruption of the
E-encoding gene. Thus,
E deficiency
appeared to function selectively in the generation/localization of IEL
and lamina propria T lymphocytes but not in the generation of organized
lymphoid tissues in the mucosa. While other explanations may exist,
these data are most consistent with a role of
Eß7 in modifying T lymphocyte localization
to the intestinal mucosa, but suggest that other receptors, such as
CD44 and possibly
Lß2 (42), may partially
compensate for the loss of
Eß7.
It was notable that the proportion of intestinal IEL that expressed the
TCR-
ß was reduced in
E-deficient mice and that the
impact of
E deficiency upon IEL number was greater in
animals that were 5 wk of age or older than in younger mice. Thus, the
impact of
E deficiency upon intestinal T lymphocyte
numbers appeared during the time period when microbial colonization
results in increased numbers of TCR
ß-expressing intestinal IEL.
Finally, the impact of
E deficiency upon IEL/lamina
propria lymphocyte (LPL) numbers may have been influenced by
environmental factors, as LPL numbers were reduced in some groups but
not others. Overall, these findings suggested that integrin
Eß7 may play a role in the
recruitment/expansion of TCR
ß+ IEL that is triggered
by microbial colonization of the intestine. Based upon the flow
cytometry analysis of IEL, it appeared that the
ß T cell subset
that was CD4+CD8- was not affected by
E deficiency. In contrast, the CD8
+,
CD8
ß+, and CD4+CD8+ subsets
were diminished to a similar extent, consistent with the expression of
Eß7 on a larger proportion of
CD8+ than of CD4+ intestinal IEL.
While reduced IEL numbers were consistent with the known function of
Eß7, we were surprised to find reduced
numbers of CD3+ cells in the intestinal lamina propria of
E-/- mice, as E-cadherin is not detected
within the lamina propria by immunohistology (Ref. 32, and our
unpublished observations). This finding suggested one of two
major possibilities, either that intestinal IEL play a role in
maintaining lamina propria lymphocyte numbers or that
Eß7 mediates another adhesive interaction
that results in the homing or retention of lymphocytes within the
lamina propria. While integrin ß7-deficient mice had
markedly reduced numbers of lamina propria T lymphocytes, we found that
intestinal IEL and lamina propria T lymphocytes were present in normal
numbers in RAG-2-deficient mice that were reconstituted with bone
marrow from
4-/- fetuses (our unpublished
observations). Taken together with the reduced lamina propria
lymphocyte number observed in
E-/- mice,
these studies suggest that
Eß7
participates in the localization of lamina propria T lymphocytes.
Additional studies will be required to define the cellular and
molecular basis for this interaction.
By comparing the impact of targeted integrin gene disruption, insight
is gained into the relative roles of the
4ß7 and
Eß7
integrins. In integrin ß7-deficient mice, there are
markedly reduced numbers of T and B cells in Peyers patches,
intestinal lamina propria, and in the intestinal epithelium (43). In
addition, in mice whose T lymphocytes lack the
4
subunit, there are reduced numbers of T and B lymphocytes in Peyers
patches, while the numbers of IEL and of lamina propria T lymphocytes
were not reduced (Ref. 44, and our unpublished observations). These
findings suggest that
4ß7 is essential for
B and T cell localization to Peyers patches, but not for T lymphocyte
localization to the intestinal epithelium or lamina propria. Finally,
in the
E-/- mice described in this report,
the number of IEL and lamina propria T lymphocytes was partially
reduced, without an impact on the localization of B or T cells to
Peyers patches. Thus, it appears that both
Eß7 and
4ß7
can function in the localization of T lymphocytes to the intestinal
lamina propria and epithelium, while
Eß7
does not mediate T lymphocyte localization to Peyers patches. The
integrin
E-deficient mice described herein will provide
an important reagent with which to further define the in vivo functions
of
Eß7, and of the cells that express it,
in health and disease.
| Acknowledgments |
|---|
E cDNA probes; H. B. Warren for histopathologic
analyses; P. Kilshaw and R. MacDonald for mAbs; C.
Nagler-Anderson for technical advice; X. Hu, E.
Meluleni, and J. Connolly for technical assistance; and M.
Hemler, V. Hsu, J. Higgins, M. Carr,
and G. J. Russell for helpful discussions. | Footnotes |
|---|
2 Current address: Department of Dermatology, Heinrich-Heine-University, Moorenstr. 5, D-40225 Düsseldorf, Germany ![]()
3 Address correspondence and reprint requests to Dr. Christina M. Parker, Brigham and Womens Hospital, Smith-552B, 1 Jimmy Fund Way, Boston, MA 02115. E-mail address: ![]()
4 Abbreviations used in this paper: IEL, intraepithelial lymphocyte; Itgae, integrin gene encoding
E; SSCP, single strand conformation polymorphism; SPF, specific pathogen-free; MFI, mean fluorescence intensity. ![]()
Received for publication January 12, 1999. Accepted for publication March 17, 1999.
| References |
|---|
|
|
|---|

and the CD8
ß TCR-
/ß murine intestinal intraepithelial T lymphocytes: evidence for the random emergence of T cells. J. Exp. Med. 180:1345.
Eß7 integrin. Eur. J. Immunol. 24:2832.[Medline]
E1 and
E2 subunits: tissue expression reveals phenotypic similarities between intraepithelial lymphocytes and dendritic cells in lymph. Eur. J. Immunol. 27:3070.[Medline]
and ß in colonic mucosa in inflammatory bowel disease. Gastroenterology 110:975.[Medline]
(IELl)ß(7) integrin on T cell receptor
-
and T cell receptor
-ß T cells. Eur. J. Immunol. 24:635.[Medline]
-e-ß-7 mediates adhesion of T-lymphocytes to epithelial cells. J. Immunol. 150:3459.[Abstract]
(E)ß(7) integrin. Nature 372:190.[Medline]
M290ß7(
E
7). Eur. J. Immunol. 25:852.[Medline]